These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6151576)

  • 41. [Improved prognosis using beta blockers after myocardial infarct?].
    Weisswange A
    Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
    Halawa B; Mazurek W
    Wiad Lek; 1986 Jan; 39(1):25-30. PubMed ID: 2872756
    [No Abstract]   [Full Text] [Related]  

  • 43. [Anti-arrythmic effects of DL-propranolol, D-propranolol and I.C.I.50 172 in experimental myocardial infarction in dogs].
    Staszewska-Barczak J
    Acta Physiol Pol; 1970; 21(3):317-29. PubMed ID: 4393011
    [No Abstract]   [Full Text] [Related]  

  • 44. Beta-adrenergic blocking agents after myocardial infarction: an undocumented need in patients at lowest risk.
    Griggs TR; Wagner GS; Gettes LS
    J Am Coll Cardiol; 1983 Jun; 1(6):1530-3. PubMed ID: 6133891
    [No Abstract]   [Full Text] [Related]  

  • 45. [Subacute thyroiditis in Londrina (State Paraná): observations on 130 cases during a period of 42 months (author's transl)].
    Calegaro JU; Calegaro NQ
    AMB Rev Assoc Med Bras; 1979 Dec; 25(12):421-6. PubMed ID: 317887
    [No Abstract]   [Full Text] [Related]  

  • 46. [Exercise test in the evaluation of effectiveness of 4 antianginal drugs (author's transl)].
    Figini A; De Ponti C; Campolo L
    G Ital Cardiol; 1974; 4(3):289-95. PubMed ID: 4152383
    [No Abstract]   [Full Text] [Related]  

  • 47. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G
    Herz; 1981 Apr; 6(2):73-83. PubMed ID: 6112196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Beta blockage after myocardial infarct].
    Frick MH; Katila M
    Duodecim; 1982; 98(2):150-7. PubMed ID: 6120827
    [No Abstract]   [Full Text] [Related]  

  • 49. The Beta-Blocker Heart Attack Trial in perspective.
    Goldstein S
    Cardiology; 1983; 70(5):255-62. PubMed ID: 6141847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Case of essential hemorrhagic thrombocythemia associated with subendocardial infarction and acute renal failure].
    Takahashi H; Koeda T; Usui Y; Nakai K; Doijiri K; Honma H; Ichikawa T; Kato M; Suzki Z
    Nihon Naika Gakkai Zasshi; 1983 May; 72(5):569-75. PubMed ID: 6685745
    [No Abstract]   [Full Text] [Related]  

  • 51. [Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)].
    Schwartz PJ
    Cardiologia; 1996 Aug; 41(8):739-45. PubMed ID: 8925528
    [No Abstract]   [Full Text] [Related]  

  • 52. Anti-arrhythmic effect of DL-propranolol, D-propranolol and I. C. I. 50 172 in experimental myocardial infarction in the dog.
    Staszewska-Barczak J
    Acta Physiol Pol; 1970; 21(3):260-70. PubMed ID: 4396953
    [No Abstract]   [Full Text] [Related]  

  • 53. Current status of beta adrenergic blockers.
    Kaul U; Wahi PL
    Indian J Chest Dis Allied Sci; 1980; 22(1):1-3. PubMed ID: 6111531
    [No Abstract]   [Full Text] [Related]  

  • 54. The use of beta blockers for the reduction of mortality after myocardial infarction.
    Hampton JR
    Eur Heart J; 1981 Aug; 2(4):259-68. PubMed ID: 6117465
    [No Abstract]   [Full Text] [Related]  

  • 55. Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs.
    Burmeister WE; Reynolds RD; Lee RJ
    Eur J Pharmacol; 1981 Oct; 75(1):7-10. PubMed ID: 6119212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. beta-Blockers and myocardial infarction.
    Moser M; Gorlin R
    Arch Intern Med; 1982 Sep; 142(9):1618-9. PubMed ID: 6126165
    [No Abstract]   [Full Text] [Related]  

  • 57. Intravenous beta-blockers during unstable angina and threatened infarction.
    Norris RM; Barnaby PF; Geary GG
    Br J Clin Pharmacol; 1982; 14 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6126205
    [No Abstract]   [Full Text] [Related]  

  • 58. Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarction.
    Willerson JT; Buja LM
    Am J Cardiol; 1984 Dec; 54(11):16E-20E. PubMed ID: 6150632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating effects of treatment in subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers.
    Yusuf S; Wittes J; Probstfield J
    Am J Cardiol; 1990 Jul; 66(2):220-2. PubMed ID: 1973589
    [No Abstract]   [Full Text] [Related]  

  • 60. Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
    Staessen J; Bulpitt C; Cattaert A; Fagard R; Vanhees L; Amery A
    Am Heart J; 1982 Dec; 104(6):1395-9. PubMed ID: 6128918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.